Artisan Partners
SAGE

Artisan Partners’s Sage Therapeutics SAGE Stock Holding History

Artisan Partners’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,521,580
Closed -$86.4M – 343
2021
Q2 		$86.4M Sell
1,521,580
-39,993
-3% -$2.83M 0.1% 194
2021
Q1 		$117M Sell
1,561,573
-31,360
-2% -$2.57M 0.15% 157
2020
Q4 		$138M Buy
1,592,933
+159,484
+11% +$11.8M 0.17% 141
2020
Q3 		$87.6M Buy
1,433,449
+218,020
+18% +$11M 0.12% 164
2020
Q2 		$50.5M Buy
1,215,429
+341,390
+39% +$12.4M 0.08% 199
2020
Q1 		$25.1M Buy
874,039
+288,600
+49% +$16.7M 0.05% 220
2019
Q4 		$42.3M Buy
585,439
+5,382
+0.9% +$662K 0.07% 201
2019
Q3 		$81.4M Sell
580,057
-6,639
-1% -$1.11M 0.15% 138
2019
Q2 		$107M Buy
586,696
+24,418
+4% +$4.17M 0.2% 115
2019
Q1 		$89.4M Buy
562,278
+311,847
+125% +$45.2M 0.18% 119
2018
Q4 		$24M Buy
+250,431
New +$28.7M 0.05% 206

Other funds holding SAGE

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Artisan Partners's SAGE Position: Q3 2021 in Review

Artisan Partners sold out of Sage Therapeutics (SAGE) in Q3 2021, closing a stake of 1,521,580 shares — an estimated $86.4M sold.

Artisan Partners first reported a position in SAGE in Q4 2018 and held it in 11 quarters. The position peaked at $138M in Q4 2020. 226 funds tracked by Wall St. Rank hold SAGE as of Q3 2021.

  • Artisan Partners reported no remaining Sage Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Artisan Partners sold 1,521,580 Sage Therapeutics shares in Q3 2021, an estimated $86.4M.
  • Artisan Partners first reported a position in Sage Therapeutics in Q4 2018 and held it in 11 quarters.
  • Artisan Partners's Sage Therapeutics position peaked at $138M in Q4 2020.
  • 226 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2021.

Based on Artisan Partners's 13F filing for Q3 2021, filed 12 Nov 2021.